Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Schilsky

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Stem Cells (Dayton, Ohio)|January 1, 1996
Methotrexate: an effective agent for treating cancer and building careers. The polyglutamate eraR L Schilsky
Seminars in Oncology|August 1, 1992
Biochemical pharmacology of chemotherapeutic drugs used as radiation enhancersR L Schilsky
Haematology and Blood Transfusion|January 1, 1987
Clinical implications of tumor heterogeneityR L Schilsky
Seminars in Oncology|September 1, 1985
Tumor cell heterogeneity: implications for clinical practiceR L Schilsky
Oncology (Williston Park, N.Y.)|November 27, 1998
Biochemical and clinical pharmacology of 5-fluorouracilR L Schilsky
Oncology (Williston Park, N.Y.)|October 18, 2000
Pharmacology and clinical status of capecitabineR L Schilsky
Journal of the National Cancer Institute|August 16, 1989
Infertility in patients with testicular cancer: testis, tumor, or treatment?R L Schilsky
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Male fertility following cancer chemotherapyR L Schilsky
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Guideposts on the journey to valueR L Schilsky
Current Oncology Reports|December 21, 2000
Immunotherapy for colorectal cancerR L Schilsky
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Stem Cells (Dayton, Ohio)|January 1, 1996
Methotrexate: an effective agent for treating cancer and building careers. The polyglutamate eraR L Schilsky
Seminars in Oncology|August 1, 1992
Biochemical pharmacology of chemotherapeutic drugs used as radiation enhancersR L Schilsky
Haematology and Blood Transfusion|January 1, 1987
Clinical implications of tumor heterogeneityR L Schilsky
Seminars in Oncology|September 1, 1985
Tumor cell heterogeneity: implications for clinical practiceR L Schilsky
Oncology (Williston Park, N.Y.)|November 27, 1998
Biochemical and clinical pharmacology of 5-fluorouracilR L Schilsky
Oncology (Williston Park, N.Y.)|October 18, 2000
Pharmacology and clinical status of capecitabineR L Schilsky
Journal of the National Cancer Institute|August 16, 1989
Infertility in patients with testicular cancer: testis, tumor, or treatment?R L Schilsky
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Male fertility following cancer chemotherapyR L Schilsky
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Guideposts on the journey to valueR L Schilsky
Current Oncology Reports|December 21, 2000
Immunotherapy for colorectal cancerR L Schilsky
Pageof 14